CALIFORNIA | LOCAL
October 6, 2010 |
Ben Horowitz, who guided the City of Hope from a relatively small tuberculosis hospital to a world-renowned cancer and medical research center, has died. He was 96. Horowitz died Saturday of natural causes at his Los Angeles home, the center announced. He was a young New York City lawyer dedicated to helping the disenfranchised when he decided to join what became known as the City of Hope, based in Duarte, in 1945. Instead of reshaping the world, Horowitz told The Times in 1986, he realized he could make a bigger contribution by taking on "just the pasture right behind me. " From 1953 through 1985, Horowitz was chief executive of the City of Hope, shepherding the institution through a dynamic era of growth.
April 7, 2008
Re "Targeted shots," editorial, April 1 As The Times points out, the best future for HIV vaccine research lies "in the laboratory and in narrower trials." But we should look beyond large vaccine candidate studies and ensure that human trials remain an integral part of the search for a safe and effective HIV vaccine. To date, HIV vaccine science has been hampered by our inability to accurately gauge a candidate's potential until it enters large-scale trials. After 25 years of research, we still know far too little about the complexities of the AIDS virus and the human immune system.
June 5, 2006 |
Francoise Barre-Sinoussi was a research associate at the Pasteur Institute in Paris when she was the first to detect the human immunodeficiency virus in 1983. She has studied the virus ever since. Barre-Sinoussi, 58, is now head of one of the institute's retroviral research groups. * PARIS -- The retroviral group begins gathering at 10 a.m. for its usual Friday meeting. Up on the screen is a picture of a spiky AIDS virus surrounded by immune cells.
CALIFORNIA | LOCAL
June 3, 2005 |
UC Irvine has been awarded a $40-million federal grant to research infectious diseases and bioterrorism. The grant, to be distributed over four years by the National Institute of Allergy and Infectious Diseases, is the largest in UCI's 40-year history and will fund the establishment of the Pacific-Southwest Center for Biodefense and Emerging Infectious Diseases Research, university officials said.
February 5, 2005
Re "NIH to Ban Deals With Drug Firms," Feb. 1: Although revisiting the concerns about potential ethical conflict caused by allowing NIH's resident scientists to accept outside income from for-profit entities is laudable and long overdue, the absolute forbidding of consulting work may activate the law of unintended consequences. The NIH, the premier biomedical research organization in the world, has some of the most knowledgeable and productive scientists in specific areas of basic research that lead to improvements for all of us. As governmental employees, they accept remuneration far below that which can be achieved in the private sector.
December 13, 2004 |
Stop. Back away from the test tube, slowly. Turn off the DNA sequencer and come out of the lab with your hands up. Get back in the classroom, where you belong. Public enthusiasm for university professors conducting research in addition to teaching undergraduates seems to have hit a new low. Articles appear every week assailing "pork" projects, spendthrift boondoggles that are generally defined as such because a writer thinks the research topic sounds ridiculous.